Yong-Hun Jo

Sein Kwon, Seulgi Baek, Hyunseo Yang et al.

Database Management Systems (DBMSs) are fundamental for managing large-scale and heterogeneous data, and their performance is critically influenced by configuration parameters. Effective tuning of these parameters is essential for adapting to diverse workloads and maximizing throughput while minimizing latency. Recent research has focused on automated configuration optimization using machine learning; however, existing approaches still exhibit several key limitations. Most tuning frameworks disregard the dependencies among parameters, assuming that each operates independently. This simplification prevents optimizers from leveraging relational effects across parameters, limiting their capacity to capture performancesensitive interactions. Moreover, to reduce the complexity of the high-dimensional search space, prior work often selects only the top few parameters for optimization, overlooking others that contribute meaningfully to performance. Bayesian Optimization (BO), the most common method for automatic tuning, is also constrained by its reliance on surrogate models, which can lead to unstable predictions and inefficient exploration. To overcome these limitations, we propose RelTune, a novel framework that represents parameter dependencies as a Relational Graph and learns GNN-based latent embeddings that encode performancerelevant semantics. RelTune further introduces Hybrid-Score-Guided Bayesian Optimization (HBO), which combines surrogate predictions with an Affinity Score measuring proximity to previously high-performing configurations. Experimental results on multiple DBMSs and workloads demonstrate that RelTune achieves faster convergence and higher optimization efficiency than conventional BO-based methods, achieving state-of-the-art performance across all evaluated scenarios.

Seungyeon Choi, Hwanhee Kim, Chihyun Park et al.

Recent advances in Structure-based Drug Design (SBDD) have leveraged generative models for 3D molecular generation, predominantly evaluating model performance by binding affinity to target proteins. However, practical drug discovery necessitates high binding affinity along with synthetic feasibility and selectivity, critical properties that were largely neglected in previous evaluations. To address this gap, we identify fundamental limitations of conventional diffusion-based generative models in effectively guiding molecule generation toward these diverse pharmacological properties. We propose CByG, a novel framework extending Bayesian Flow Network into a gradient-based conditional generative model that robustly integrates property-specific guidance. Additionally, we introduce a comprehensive evaluation scheme incorporating practical benchmarks for binding affinity, synthetic feasibility, and selectivity, overcoming the limitations of conventional evaluation methods. Extensive experiments demonstrate that our proposed CByG framework significantly outperforms baseline models across multiple essential evaluation criteria, highlighting its effectiveness and practicality for real-world drug discovery applications.